472.1Isolated intestine transplantation for short gut syndrome in the era of GLP-2 agonist
Yaron Avitzur (CA)
Evolving strategies in intestinal and multivisceral transplantation
Chairs
Helen Evans (NZ)
· Rajith Amaratunga (AU)
Presentations
472.2Novel immunosuppression in intestine transplantation
Jennifer Garcia (US)
472.3Pros and cons of protocol biopsy and stoma
Jonathan Hind (AU)
472.4Multivisceral transplantation: Patient selection, surgical challenges, and outcomes
Graham Starkey (AU)